NDC 72934-1042

CICLOPIROX 3%

Ciclopirox 3%

CICLOPIROX 3% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Ciclopirox Olamine.

Product ID72934-1042_89574010-4281-0d72-e053-2995a90a5295
NDC72934-1042
Product TypeHuman Prescription Drug
Proprietary NameCICLOPIROX 3%
Generic NameCiclopirox 3%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-20
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameCICLOPIROX OLAMINE
Active Ingredient Strength3 g/100g
Pharm ClassesDecreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1042-2

30 g in 1 BOTTLE, PUMP (72934-1042-2)
Marketing Start Date2019-05-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1042-2 [72934104202]

CICLOPIROX 3% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-20

Drug Details

Active Ingredients

IngredientStrength
CICLOPIROX OLAMINE3 g/100g

OpenFDA Data

SPL SET ID:89574010-4280-0d72-e053-2995a90a5295
Manufacturer
UNII

Pharmacological Class

  • Decreased DNA Replication [PE]
  • Decreased Protein Synthesis [PE]
  • Decreased RNA Replication [PE]
  • Protein Synthesis Inhibitors [MoA]
  • Decreased DNA Replication [PE]
  • Decreased Protein Synthesis [PE]
  • Decreased RNA Replication [PE]
  • Protein Synthesis Inhibitors [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.